Perioperative Infection Transmission: the Role of the Anesthesia Provider in Infection Control and Healthcare-Associated Infections

Sharma, Archit; Fernandez, Patrick; Rowlands, John; Koff, Matthew D.; Loftus, Randy W.

doi:10.1007/s40140-020-00403-8

Cited by 14 publications

(12 citation statements)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reported incidence of HAI is 5–10%, increasing up to 30% for intensive care unit patients; the use of invasive devices (e.g. central lines) is associated with an increased risk [ 2 , 3 ]. HAI prevention is a priority for reducing patient morbidity, mortality and costs.…”

Section: Introductionmentioning

confidence: 99%

Hospital Acquired Infections in Surgical Patients: Impact of COVID‐19‐Related Infection Prevention Measures

et al. 2022

View full text Add to dashboard Cite

Background Hospital acquired infections are common, costly, and potentially preventable adverse events. This study aimed to determine the effect of the COVID-19 pandemic-related escalation in infection prevention and control measures on the incidence of hospital acquired infection in surgical patients in a low COVID-19 environment in Australia. Method This was a retrospective cohort study in a tertiary institution. All patients undergoing a surgical procedure from 1 April 2020 to 30 June 2020 (COVID-19 pandemic period) were compared to patients pre-pandemic (1 April 2019–30 June 2019). The primary outcome investigated was odds of overall hospital acquired infection. The secondary outcome was patterns of involved microorganisms. Univariable and multivariable logistic regression analysis was performed to assess odds of hospital acquired infection. Results There were 5945 admission episodes included in this study, 224 (6.6%) episodes had hospital acquired infections in 2019 and 179 (7.1%) in 2020. Univariable logistic regression analysis demonstrated no evidence of change in odds of having a hospital acquired infection between cohorts (OR 1.08, 95% CI 0.88–1.33, P = 0.434). The multivariable regression analysis adjusting for potentially confounding co-variables also demonstrated no evidence of change in odds of hospital acquired infection (OR 0.93, 95% CI 0.74–1.16, P = 0.530). Conclusion Increased infection prevention and control measures did not affect the incidence of hospital acquired infection in surgical patients in our institution, suggesting that there may be a plateau effect with these measures in a system with a pre-existing high baseline of practice.

show abstract

Section: Introductionmentioning

confidence: 99%

Hospital Acquired Infections in Surgical Patients: Impact of COVID‐19‐Related Infection Prevention Measures

et al. 2022

View full text Add to dashboard Cite

show abstract

“… 29 Sharma et al emphasize the role of the anesthesiologist in the prevention of SSIs. 30 Reporting on a study endorsed by the Global Alliance for Infections in Surgery, Sartelli and colleagues note the importance of healthcare workers behaviours and organizational characteristics and emphasize involving patients in the implementation of prevention protocols. 31 Finally, Cerulli Irelli et al argue that while calls for action by international agencies during the last years to improve programs for infection prevention and control worldwide have been undermined, in the midst of a health emergency of the COVID‐19 pandemic, many countries successfully rapidly planned and implemented more efficient hygiene protocols in their hospitals and it would be mistaken to waste the opportunity offered by COVID‐19 to improve infection prevention and control.…”

Section: Discussionmentioning

confidence: 99%

A retrospective cohort study of the impact of COVID‐19 infection control measures on surgical site infections in an academic hospital setting

Teymourian,

ArianNik,

Mohit

et al. 2024

International Wound Journal

View full text Add to dashboard Cite

Previous studies show that both the frequency of surgeries and incidence of surgical site infections (SSIs) have been lower during the coronavirus disease 2019 (COVID‐19) pandemic. This study's purpose is to analyse the possible association of the COVID‐19 epidemic‐related increased health measures, such as protective equipment and products, increased hand hygiene and restrictions imposed, on the incidence of SSIs in an academic medical centre. We designed a single‐centre, retrospective cohort study and collected data on the frequency of surgeries and the incidence of SSIs, among patients who had surgeries pre‐ and post‐COVID‐19 pandemic. Besides the intervention and outcome variable, we sought information on patient gender, surgery type, body mass index (BMI), smoking, and type II diabetes mellitus. We used Wald 95% confidence interval (95% CI) and the p values of the odds ratio (OR) to report results. Of the N = 24 098 surgeries performed in this hospital, there were 269 patients who reported post‐surgical SSIs in this hospital between March 2019 and March 2021. The OR of developing a post‐surgical SSI was 0.40 (95% CI: 0.33–0.57, p < 0.05; adjusted for confounders 0.39 [95% CI: 0.30–0.52, p < 0.05]) among patients who had surgery under post‐pandemic infection control measures, as compared to patients who had surgery under pre‐pandemic usual care infection control measures. Our significant results conclude that an association may exist between the enhanced infection control measures used during the COVID‐19 pandemic and lower incidence of SSIs we observed during this period.

show abstract

“…The bundle focuses on hand hygiene, environmental cleansing, patient decolonization, vascular care and surveillance. The study concludes by stating that the bundle can be applied not only to the prevention of perioperative infections but is also standard to clinical practices in the prevention of infections such as that of SARS-CoV-2 [ 141 ].…”

Section: Implementation Of Surgical Site Infections Prevention Measuresmentioning

confidence: 99%

Prevention of Surgical Site Infections in Neonates and Children: Non-Pharmacological Measures of Prevention

et al. 2022

View full text Add to dashboard Cite

A surgical site infection (SSI) is an infection that occurs in the incision created by an invasive surgical procedure. Although most infections are treatable with antibiotics, SSIs remain a significant cause of morbidity and mortality after surgery and have a significant economic impact on health systems. Preventive measures are essential to decrease the incidence of SSIs and antibiotic abuse, but data in the literature regarding risk factors for SSIs in the pediatric age group are scarce, and current guidelines for the prevention of the risk of developing SSIs are mainly focused on the adult population. This document describes the current knowledge on risk factors for SSIs in neonates and children undergoing surgery and has the purpose of providing guidance to health care professionals for the prevention of SSIs in this population. Our aim is to consider the possible non-pharmacological measures that can be adopted to prevent SSIs. To our knowledge, this is the first study to provide recommendations based on a careful review of the available scientific evidence for the non-pharmacological prevention of SSIs in neonates and children. The specific scenarios developed are intended to guide the healthcare professional in practice to ensure standardized management of the neonatal and pediatric patients, decrease the incidence of SSIs and reduce antibiotic abuse.

show abstract

Perioperative Infection Transmission: the Role of the Anesthesia Provider in Infection Control and Healthcare-Associated Infections

Cited by 14 publications

References 73 publications

Hospital Acquired Infections in Surgical Patients: Impact of COVID‐19‐Related Infection Prevention Measures

Hospital Acquired Infections in Surgical Patients: Impact of COVID‐19‐Related Infection Prevention Measures

A retrospective cohort study of the impact of COVID‐19 infection control measures on surgical site infections in an academic hospital setting

Prevention of Surgical Site Infections in Neonates and Children: Non-Pharmacological Measures of Prevention

Contact Info

Product

Resources

About